Compare CPAY & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPAY | STE |
|---|---|---|
| Founded | 1986 | 1985 |
| Country | United States | United States |
| Employees | N/A | 3700 |
| Industry | EDP Services | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.2B | 22.3B |
| IPO Year | 2010 | 2018 |
| Metric | CPAY | STE |
|---|---|---|
| Price | $329.91 | $221.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $378.91 | $275.20 |
| AVG Volume (30 Days) | 670.9K | ★ 797.1K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.13% |
| EPS Growth | 7.59 | ★ 62.73 |
| EPS | ★ 15.03 | 5.69 |
| Revenue | $4,528,403,000.00 | ★ $5,459,515,000.00 |
| Revenue This Year | $18.85 | $9.88 |
| Revenue Next Year | $10.52 | $6.32 |
| P/E Ratio | ★ $21.91 | $39.17 |
| Revenue Growth | ★ 13.93 | 6.24 |
| 52 Week Low | $252.84 | $204.90 |
| 52 Week High | $361.99 | $269.44 |
| Indicator | CPAY | STE |
|---|---|---|
| Relative Strength Index (RSI) | 50.39 | 24.48 |
| Support Level | $315.81 | N/A |
| Resistance Level | $338.47 | $254.67 |
| Average True Range (ATR) | 12.12 | 5.34 |
| MACD | -1.60 | -2.71 |
| Stochastic Oscillator | 45.83 | 9.27 |
Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. The company offers payment and spend management solutions, including accounts payable automation, cross-border payments, commercial card programs, vehicle payment solutions, and lodging payment services. Its reportable segments are: Corporate Payments, Vehicle Payments, Lodging Payments and Other. The majority of the company's revenue is derived from the Vehicle Payments segment, which helps customers to pay for vehicle related expenses. Geographically, it derives the maximum revenue from the United States and the rest from Brazil, the United Kingdom and other countries.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.